Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,542 | 0 | 0 | 0 | 34,826 |
| Marketable Securities | 17,296 | 0 | 0 | 0 | 0 |
| Other current assets | 0 | 0 | 0 | 0 | 1,074 |
| TOTAL | $25,361 | $0 | $0 | $0 | $35,900 |
| Non-Current Assets | |||||
| PPE Net | 4,083 | N/A | N/A | N/A | 2,032 |
| Other Non-Current Assets | 17,098 | 0 | 0 | 0 | 1,030 |
| TOTAL | $21,181 | $N/A | $N/A | $N/A | $3,062 |
| Total Assets | $46,542 | $0 | $0 | $0 | $48,447 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,598 | 0 | 0 | 0 | 2,095 |
| Accrued Expenses | 6,663 | 0 | 0 | 0 | 2,866 |
| Other current liabilities | N/A | 0 | 0 | 0 | 599 |
| TOTAL | $11,264 | $0 | $0 | $0 | $8,656 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,502 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 25,553 | 0 | 0 | 0 | 71 |
| TOTAL | $34,929 | $N/A | $N/A | $N/A | $8,132 |
| Total Liabilities | $46,193 | $0 | $0 | $0 | $16,788 |
| Shareholders' Equity | |||||
| Retained earnings | -108,399 | 0 | 0 | 0 | -47,671 |
| Other shareholders' equity | 105,296 | 0 | 0 | 0 | 77,505 |
| TOTAL | $349 | $0 | $0 | $0 | $31,659 |
| Total Liabilities And Equity | $46,542 | $0 | $0 | $0 | $48,447 |